Abeona Therapeutics (ABEO) Competitors $5.69 -0.01 (-0.18%) (As of 05:26 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ABEO vs. COLL, SEPN, ZYME, BCAX, GYRE, LQDA, PCRX, PAHC, COGT, and NUVBShould you be buying Abeona Therapeutics stock or one of its competitors? The main competitors of Abeona Therapeutics include Collegium Pharmaceutical (COLL), Septerna (SEPN), Zymeworks (ZYME), Bicara Therapeutics (BCAX), Gyre Therapeutics (GYRE), Liquidia (LQDA), Pacira BioSciences (PCRX), Phibro Animal Health (PAHC), Cogent Biosciences (COGT), and Nuvation Bio (NUVB). These companies are all part of the "pharmaceutical preparations" industry. Abeona Therapeutics vs. Collegium Pharmaceutical Septerna Zymeworks Bicara Therapeutics Gyre Therapeutics Liquidia Pacira BioSciences Phibro Animal Health Cogent Biosciences Nuvation Bio Collegium Pharmaceutical (NASDAQ:COLL) and Abeona Therapeutics (NASDAQ:ABEO) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk, media sentiment, earnings and community ranking. Do analysts prefer COLL or ABEO? Collegium Pharmaceutical presently has a consensus target price of $42.60, indicating a potential upside of 46.14%. Abeona Therapeutics has a consensus target price of $18.00, indicating a potential upside of 216.34%. Given Abeona Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Abeona Therapeutics is more favorable than Collegium Pharmaceutical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Collegium Pharmaceutical 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60Abeona Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, COLL or ABEO? Collegium Pharmaceutical has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500. Comparatively, Abeona Therapeutics has a beta of 1.44, meaning that its stock price is 44% more volatile than the S&P 500. Does the media refer more to COLL or ABEO? In the previous week, Collegium Pharmaceutical had 3 more articles in the media than Abeona Therapeutics. MarketBeat recorded 6 mentions for Collegium Pharmaceutical and 3 mentions for Abeona Therapeutics. Collegium Pharmaceutical's average media sentiment score of 0.98 beat Abeona Therapeutics' score of 0.66 indicating that Collegium Pharmaceutical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Collegium Pharmaceutical 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Abeona Therapeutics 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better earnings & valuation, COLL or ABEO? Collegium Pharmaceutical has higher revenue and earnings than Abeona Therapeutics. Abeona Therapeutics is trading at a lower price-to-earnings ratio than Collegium Pharmaceutical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCollegium Pharmaceutical$599.25M1.57$48.15M$2.3212.56Abeona Therapeutics$3.50M70.67-$54.19M-$2.69-2.12 Do insiders & institutionals have more ownership in COLL or ABEO? 80.6% of Abeona Therapeutics shares are owned by institutional investors. 4.0% of Collegium Pharmaceutical shares are owned by company insiders. Comparatively, 5.4% of Abeona Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is COLL or ABEO more profitable? Collegium Pharmaceutical has a net margin of 14.78% compared to Abeona Therapeutics' net margin of 0.00%. Collegium Pharmaceutical's return on equity of 104.67% beat Abeona Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Collegium Pharmaceutical14.78% 104.67% 18.38% Abeona Therapeutics N/A -203.27%-64.56% Does the MarketBeat Community believe in COLL or ABEO? Abeona Therapeutics received 137 more outperform votes than Collegium Pharmaceutical when rated by MarketBeat users. Likewise, 69.88% of users gave Abeona Therapeutics an outperform vote while only 65.25% of users gave Collegium Pharmaceutical an outperform vote. CompanyUnderperformOutperformCollegium PharmaceuticalOutperform Votes38565.25% Underperform Votes20534.75% Abeona TherapeuticsOutperform Votes52269.88% Underperform Votes22530.12% SummaryCollegium Pharmaceutical beats Abeona Therapeutics on 9 of the 17 factors compared between the two stocks. Ad Brownstone ResearchCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.Click here to see the details because I believe a lot of people will get rich. Get Abeona Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABEO vs. The Competition Export to ExcelMetricAbeona TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$247.35M$6.69B$5.20B$9.14BDividend YieldN/A3.00%5.12%4.29%P/E Ratio-2.1210.6087.0517.14Price / Sales70.67193.811,138.53122.78Price / CashN/A57.1643.2337.84Price / Book9.485.134.804.78Net Income-$54.19M$151.58M$120.46M$225.43M7 Day Performance-3.40%0.01%-0.84%-0.68%1 Month Performance-4.85%-3.72%14.79%1.03%1 Year Performance14.49%9.07%29.53%15.71% Abeona Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABEOAbeona Therapeutics3.8765 of 5 stars$5.69-0.2%$18.00+216.3%+14.7%$247.35M$3.50M-2.12N/AAnalyst UpgradeNews CoverageCOLLCollegium Pharmaceutical3.9439 of 5 stars$30.68+2.0%$42.60+38.9%-1.2%$989.43M$599.25M12.97210News CoverageSEPNSepterna2.0227 of 5 stars$21.96-1.9%$43.67+98.8%N/A$975.02MN/A0.00N/ANews CoverageZYMEZymeworks2.8092 of 5 stars$13.85+10.1%$18.83+36.0%+43.8%$953.99M$76.01M-9.25290BCAXBicara TherapeuticsN/A$17.50flat$43.00+145.7%N/A$952.28MN/A0.0032GYREGyre Therapeutics0.5866 of 5 stars$10.14+5.2%N/A-62.5%$948.30M$105.03M0.0040News CoverageGap UpLQDALiquidia3.2787 of 5 stars$11.07+1.4%$24.00+116.8%-5.7%$936.93M$15.61M-6.7050Analyst ForecastPCRXPacira BioSciences3.7915 of 5 stars$19.99+0.7%$23.50+17.6%-42.6%$922.94M$674.98M-9.78720PAHCPhibro Animal Health4.0373 of 5 stars$22.74+0.3%$19.00-16.4%+93.5%$921.04M$1.05B52.561,940COGTCogent Biosciences2.3237 of 5 stars$8.28+1.6%$14.83+79.1%+36.6%$914.61MN/A-3.2980NUVBNuvation Bio2.3933 of 5 stars$2.68+2.7%$6.60+146.3%+79.9%$902.01MN/A0.0060Analyst ForecastGap Up Related Companies and Tools Related Companies Collegium Pharmaceutical Alternatives Septerna Alternatives Zymeworks Alternatives Bicara Therapeutics Alternatives Gyre Therapeutics Alternatives Liquidia Alternatives Pacira BioSciences Alternatives Phibro Animal Health Alternatives Cogent Biosciences Alternatives Nuvation Bio Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ABEO) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abeona Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Abeona Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABEO Stock Alerts